Dental Biomaterial Market - Forecasts from 2022 to 2027

The global dental biomaterial market is expected to grow at a CAGR of 10.38% over the forecast period to reach a total market size of US$14.296 billion by 2027, increasing from US$7.163 billion in 2020.

Dental biomaterials include all types of natural and biocompatible synthetic materials used to restore damaged and decayed teeth. The increasing prevalence of dental disorders coupled with the rising penetration of dental implants is expected to drive the growth of the market during the forecast period. However, stringent regulation and the clinical process are anticipated to restrain the growth of the market in the coming years.

Dental implants and prosthetics are mostly used either for filling oral cavities or replacing them with a concrete solution and according to the World Health Organization, more than 3 billion people in the world are affected by oral health problems. A dental implant is a kind of oral prosthetic in which the gum is opened and in the cavity is positioned a prosthetic crown. Planning the position and number of implants is key to the long-term health of the prosthetic since biomechanical forces created during chewing can be significant.

The growing geriatric population is driving the growth of the market

The global population is ageing, and every country is experiencing growth in the old age proportion of elderly people in the total population. Poor oral health among older people is evident in a high level of tooth loss, and all types of periodontal disease. According to the recent report titled World Population Prospects by the United Nations, by 2050, one in every six people in the world will be over age 65 (16%), from one in 11 in 2019 (9%) and the number of people aged 80 years or above is projected to triple, from 143 million in 2019 to 426 million in 2050.

Material analysis

By material, the dental biomaterial market has been segmented into metallic biomaterials, ceramic biomaterials, and polymeric biomaterials, among others. The metallic biomaterial segment is projected to hold a significant share, owing to the benefits offered by titanium material, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion resistance properties.

Application insight

By application, the dental biomaterial market is segmented based on implantology, prosthodontics, and orthodontics, among other applications. The implantology application segment accounted for a significant share of the market on account of the increasing penetration of dental implants in developing countries like China, India, and Brazil. In addition, the rising demand for cosmetic dentistry, expanding dental tourism in emerging markets, coupled with increasing disposable incomes in developing countries, are further expected to boost the growth of the market in the coming years.

North America will hold a significant share in the market over the forecast period

By geography, the dental biomaterial market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. The North American region is expected to hold a significant share in the market owing to the presence of major players coupled with the growing geriatric population. In Europe, favourable government initiatives on oral healthcare, combined with increased adoption of dental biomaterials for the fabrication of implants and other dental products, are expected to drive the regional market in the coming years. Besides, rising disposable income and the growing number of dental hospitals, the market for dental biomaterials is anticipated to witness exponential growth in the Asia Pacific region.

Competitive Insights

Prominent key market players in the dental biomaterial market include Straumann AG, Royal DSM, Medtronic Plc, Danaher Corporation, Geistlich Pharma AG, Zimmer Biomet Holdings, 3M Company, Dentsply Sirona, Inc, Kuraray Co., Ltd, and Mitsui Chemicals, Inc. The number of players in the dental biomaterial market is large and growing, with the opportunity to generate significant revenues because of the growing demand for various applications. The players in the global dental biomaterial market are implementing various growth strategies to gain a competitive advantage over their competitors in this market and are now focusing on the developing region due to the rising disposable income and increasing healthcare expenditure. Key players in this market are focusing on strategic acquisitions, collaborative partnerships, and investment in new geographical boundaries as a part of their growth strategies to provide products to their consumers worldwide. For instance, in July 2018, Straumann Group acquired a nearly 30% stake in its biomaterials partner, Botiss medical AG, for an undisclosed sum. Botiss is a fast-growing, entrepreneurial company that has already become a leading provider of biomaterials for oral surgery and the acquisition agreement enables Straumann to expand its global distribution network of Botiss products. Major market players in the global dental biomaterial market have been covered along with their relative competitive positions and strategies. The report also mentions recent deals and investments by different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered, along with the recent deals and investments of these important players in the global dental biomaterial market.

Key developments in the market:

December 2020: Sonoma Pharmaceuticals, Inc., a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products for a variety of applications, disinfectant use, and dermatological conditions, announced its entry into a non-exclusive distribution agreement with Gabriel Science into the dental market.

February 2022: Ultradent Products, Inc., a global producer of high-tech dental materials and equipment, announced the launch of MTApex bioceramic root canal sealer, a new endodontic product.

Covid-19 Insights:

COVID-19 had a negative impact on the dental biomaterial market. The rise in infected cases and mandated lockdown decreased the number of patient visits to dental clinics. According to a survey conducted by Global Dental Council, approximately 69% of dental business owners reported their average monthly dental business income had declined in 2020 compared to the previous year's average monthly income. At the same time, over a third (35%) expected their income to remain lower than before COVID in the upcoming year.

Segmentation:

By Material

• Metallic Biomaterials
• Titanium
• Stainless Steel
• Other
• Ceramic Biomaterials
• Polymeric Biomaterials

By Application

• Implantology
• Prosthodontics
• Orthodontics

By End-user

• Hospitals
• Clinics
• Academies and Research Laboratories

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Europe
• Germany
• Spain
• United Kingdom
• France
• Middle East and Africa
• Saudi Arabia
• UAE
• Asia Pacific
• China
• Japan
• India
• Indonesia
• Thailand
• Taiwan